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Abstract – Solute analysis in bronchoalveolar lavage fluid involves the use of dilutional markers to
correct for variable recovery of pulmonary epithelial lining fluid (PELF). Urea is the best characterised
endogenous marker, whereas inulin appears to meet the requirements of an exogenous marker. In
horses, the use of inulin has never been investigated and the impact of lower airway diseases such as
heaves, on PELF recovery is unknown. In this study, five healthy and five heaves-affected horses under-
went airway endoscopy and bronchoalveolar lavage. PELF recovery from bronchoalveolar lavage was
calculated by the inulin and the urea method. The inulin method was compared to the urea method and
differences between healthy and heaves-affected horses were analysed. From a technical and analytical
point of view, inulin fulfilled the requirements of a marker of dilution as well as urea. When both
healthy and heaves-affected horses groups were pooled together, PELF recovery calculated by the inulin
method was significantly higher than by the urea method (6.43 ± 4.08% versus 0.789 ± 0.299%, P <
0.005). No significant differences were observed between healthy and heaves-affected horses, neither
by the inulin nor by the urea method. Inulin did not present major advantages over urea, but the
combined use of both markers can improve the standardisation of studies comparing PELF com-
pounds, by providing upper limits (inulin dilution) and lower limits (urea dilution) of PELF 
recovery.
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Résumé – Comparaison de l’inuline et de l’urée en tant que marqueurs de dilution de lavage
bronchoalvéolaire chez des chevaux sains et des chevaux poussifs. L’analyse des composants
du liquide de lavage bronchoalvéolaire implique fréquemment l’utilisation de facteurs de dilution afin
de pouvoir corriger la récupération très variable du fluide épithélial pulmonaire (FEP). Parmi les
marqueurs utilisés, l’urée est le marqueur endogène le mieux caractérisé, tandis que l’inuline possède
toutes les caractéristiques requises d’un marqueur de dilution exogène. L’inuline n’a jamais été 
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1. INTRODUCTION
In the airways, the pulmonary epithelial
lining fluid (PELF) forms an interface
between the underlying respiratory tract and
the external environment. It contains numer-
ous pulmonary mediators and metabolites,
the role of which is often investigated in
lower airway disease. Bronchoalveolar
lavage is a simple and safe technique for
collecting cellular and molecular compo-
nents from the lung. However, the quantity
of PELF washed out of the lung in the return
bronchoalveolar lavage fluid (BALF) is
unknown and variable [5]. This uncertainty
limits the interpretation of measured solute
concentrations and complicates comparisons
between lavages. Therefore, a marker sub-
stance indicating the degree to which PELF
has been diluted in the return fluid of bron-
choalveolar lavage is useful. Different stud-
ies have investigated exogenous and endoge-
nous components as markers of PELF
dilution [3, 5–7, 10, 11]. 
Methylene blue, radioactive tracers
(99mTC-diethylenetriamine pentaacetate,
51Cr-EDTA) and inulin have been studied as
exogenous markers of BALF dilution [4,
11, 14]. The criteria for an ideal external
marker are (1) that the only source of the
marker is the instilled lavage fluid, (2) that
the marker is inert, (3) that it is not taken
up or metabolised by cells, (4) that it does
not cross the pulmonary epithelium and (5)
that it mixes completely with the PELF in
the lavaged lung segment [11]. Methylene
blue has been shown to bind to cells or to
diffuse into the pulmonary interstitium [3,
10], leading to substantial overestimation
of recovered PELF. Moreover, its addition
to lavage fluid may strongly interfere with
further analysis of BALF compounds. The
use of radioactive tracers is often unsuitable
for routine use or experimental protocols.
Inulin, an inert polysaccharide of high
molecular weight (5 kDa), is not naturally
present in the body. Furthermore, it is not
absorbed or metabolised by cells, nor does
it cross the alveolar epithelium [11]. Finally,
it can be easily assayed spectrophotometri-
cally by the method of Roe [13]. Therefore,
this compound meets the requirements of
an effective external marker [11].
The use of endogenous markers is based
on the assumption that their concentrations
are uniform throughout the lung, identical in
all patients and independent of airway dis-
ease. In the special case of urea, it is fur-
thermore presumed that PELF urea con-
centrations are identical to those in plasma
[7]. Determination of these markers in
BALF makes it possible to standardise the
étudiée dans l’espèce équine en tant que marqueur de dilution du lavage bronchoalvéolaire. De plus,
l’impact des maladies respiratoires pulmonaires, telle que la pousse, sur le taux de récupération du FEP
lors de lavage bronchoalvéolaire, n’a pas été étudié dans l’espèce équine. Dans cette étude, cinq
chevaux sains et cinq chevaux atteints de pousse ont subi des lavages bronchoalvéolaires au cours d’une
endoscopie des voies respiratoires inférieures. La récupération du FEP a été calculée au moyen de la
méthode de l’inuline ainsi qu’au moyen de la méthode de l’urée. Les résultats issus des deux techniques
ont été comparés, pour les chevaux sains et les chevaux atteints de pousse. D’un point de vue tech-
nique et analytique, l’utilisation de l’inuline en tant que facteur de dilution était aussi satisfaisante que
celle de l’urée. Lorsqu’il n’y a pas eu de distinction entre les chevaux sains et les chevaux poussifs,
le taux de récupération du FEP calculé au moyen de la méthode de l’inuline était significativement
plus élevé que celui calculé au moyen de la méthode de l’urée (6,43 ± 4,08 % et 0,789 ± 0,299 % res-
pectivement, P < 0,005). Aucune différence significative entre les chevaux sains et les chevaux
poussifs n’a été observée, quelle qu’ait été la méthode utilisée. La méthode de l’inuline ne présentait
pas d’avantages majeurs comparée à celle de l’urée, mais l’utilisation simultanée des deux méthodes
peut néanmoins améliorer la standardisation des études du FEP, en fournissant des limites supé-
rieures (inuline) et inférieures (urée) du taux de récupération du FEP.
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concentrations of PELF within BALF sam-
ples. The most commonly used endogenous
markers are urea and albumin [5, 7, 10, 14].
Sphingomyelin, IgA secretory component,
total protein, Na+, Cl– and Ca2+ have also
been investigated [5, 14]. Among the inter-
nal markers, urea is the best known and its
validity has been largely investigated [10,
14]. There are some concerns that diffusion
of urea from the interstitial fluid into the
lavage fluid may occur. The urea influx
would lead to an overestimation of PELF
recovery. What is referred to as dwell time,
i.e. the time lavage fluid remains in the air-
ways before being re-aspirated, is a corner-
stone in the standardisation of the bron-
choalveolar lavage technique. With
increasing dwell time, BALF urea concen-
tration increases and consequently, PELF
recovery is overestimated [6, 10]. Never-
theless, PELF urea concentration has been
shown to be independent of lung disease,
which is not the case for albumin, whose
diffusion rate is increased by airway inflam-
mation [5]. 
Bronchoalveolar lavage is commonly
performed in horses suffering from lower
airway disease, especially in horses suffer-
ing from heaves [12]. Indeed, research into
equine lung disease focuses on inflamma-
tory mediators and other compounds, whose
concentration in BALF does not reflect the
actual concentration of molecules recovered
in PELF. To circumvent this problem, urea
and albumin have been proposed as dilu-
tional markers [7], but the above-mentioned
concerns regarding these compounds remain
for the equine species. Large lavage vol-
umes (100–200 mL) are often used for bron-
choalveolar lavage in horses. Therefore,
duration of BALF recovery can be variable.
This renders standardisation of the dwell
time difficult, which limits the accuracy of
urea as a dilutional marker. An external
marker, whose dilution by PELF is inde-
pendent of the time lavage fluid remains in
the airways, would be more appropriate.
Inulin has been shown to be an easy and sat-
isfactory external marker of PELF in
humans [11], but has never been tested in
horses. Furthermore, it is not known whether
lower airway disease has an impact on PELF
dilution.
In this protocol, five horses free of air-
way diseases and five horses with heaves
in acute crisis were studied. The aims of our
study were: (1) to compare the inulin method
to the urea method for the calculation of
PELF dilution and (2) to examine whether
airway disease has an influence on PELF
dilution, calculated either by the inulin or
the urea method. 
2. MATERIALS AND METHODS
The study was approved by the ethical
committee of the Faculty of Veterinary
Medicine. 
2.1. Horses
Five healthy horses and five horses with
heaves in acute crisis were studied. The
healthy animals were chosen on the basis
of their age (3–9 years) and the absence of
respiratory disorders when bedded on straw
and fed hay. The heaves-affected horses
were selected on the basis of their history
of airway obstruction and their bron-
chodilatory response to intravenously
injected atropine (0.02 mg·kg–1 body-
weight). An acute crisis of heaves was
induced by bedding horses on straw and
feeding them mouldy hay. The onset of cri-
sis occurred 48 to 72 h after exposure to
hay. Before starting the protocol, all horses
underwent pulmonary function tests in order
to confirm that they were in the appropri-
ate clinical state.
2.2. Pulmonary function tests
Pulmonary function tests consisted in
measuring the mechanics of breathing 
and analysing arterial gas tension. The 
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mechanics of breathing required pleural
pressure and respiratory airflow measure-
ments. Respiratory airflow and oesophageal
pressure were simultaneously measured and
total pulmonary resistance (RL), dynamic
compliance (Cdyn) and maximal pleural
pressure changes ( D pplmax) were immedi-
ately calculated by a computerised system
(Ponemah, Gould Instrument Systems, Valley
View, OH, USA). The following limits were
arbitrarily chosen to control whether the
animals were healthy or suffering a crisis
of heaves: healthy: RL £ 0.10 kPa·s·L–1,
Cdyn ‡ 10 L·kPa–1, D pplmax £ 1.00 kPa;
suffering a crisis of heave : RL ‡
0.25 kPa·s·L–1, Cdyn £ 10 L·kPa–1, D pplmax
‡ 2.50 kPa. Further details about the 
measurement technique are reported 
elsewhere [1].
Arterial blood was withdrawn anaerobi-
cally by puncture of Arteria carotis com-
munis and analysed, after correction for
body temperature, for partial pressure in O2(AVL 995, VEL, Leuven, Belgium). PaO2
‡ 90 mmHg was considered to be accept-
able in healthy horses and PaO2 £ 80 mmHg
was required for horses suffering a crisis. 
Results of the pulmonary function tests
are reported in Table I.
2.3. Airway endoscopy 
and bronchoalveolar lavage
Endoscopy of the airways and bron-
choalveolar lavage were performed on the
sedated horse (Sedivet®, Boehringer Ingel-
heim, Ingelheim, Germany, romifidine,
0.01 mg·kg–1 bodyweight intravenously).
A fibreoptic endoscope (250 cm in length, 
9 mm in diameter) (Pentax, Breda, The
Netherlands) was wedged into the locally
anaesthetised bronchi, and previously pre-
pared saline containing 0.5 mg·mL–1 inulin
was instilled in situ. The procedure was stan-
dardised by injecting a 60 mL aliquot of
prepared saline into the bronchi and col-
lecting it as soon as the instillation was per-
formed (dwell time < 15 s). Three consecu-
tive instillations were performed at the same
site. There was no possibility of measuring
the applied negative pressure for fluid aspi-
ration, but a single operator performed all
lavages and attempted to standardise the
aspiration procedure. The lavage was con-
sidered successful when alveolar surfactant
and more than 60% of saline were aspirated.
BALF was pooled, immediately cooled on
ice and processed for definitive storage until
analysis (see processing description below). 
2.4. Saline preparation 
for bronchoalveolar lavage 
and inulin standard dilutions
Saline (0.9% NaCl) was heated at 37 °C
in a water bath and inulin was added in order
to obtain an initial inulin concentration of
0.5 mg·mL–1 saline. Heating was necessary
for the successful dissolution of inulin. Five
samples of prepared saline were stored at
–80 °C for determination of initial inulin
concentration. On the same occasion, dilu-
tions for a standard curve were prepared
(dilution of 1.000, 0.900, 0.810, 0.729, 0.656
Table I. Pulmonary function tests. Values are presented as means ± SD.
Variable Unit Healthy horses Heaves-affected horses
(n = 5) (n = 5)
RL kPa·s·L–1 0.07 ± 0.01 0.28 ± 0.06*
Cdyn L·kPa–1 17.9 ± 6.2 5.8 ± 1.9*
D pplmax kPa 0.66 ± 0.32 3.33 ± 0.82*
PaO2 mmHg 98.8 ± 7.9 71.3 ± 4.5*
* Significantly different from healthy horses, P < 0.05.
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and 0.590 of the initial solution) and equally
stored at –80 °C until use.
2.5. Bronchoalveolar lavage fluid 
treatment
Recovered bronchoalveolar lavage fluid
(BALF) was divided into two portions, for
inulin and urea, respectively. The first por-
tion was centrifuged at 400 · g for 10 min
and the supernatant was withdrawn and
stored at –80 °C for later inulin determina-
tion. Three samples were stored for each
horse. The second portion was aliquoted
into three samples and stored at –80 °C for
urea analysis. 
2.6. Plasma treatment for urea 
determination
Immediately after bronchoalveolar
lavage, venous blood was sampled by jugu-
lar puncture and heparinised. After cen-
trifugation (10 min, 900 · g), plasma was
withdrawn and aliquoted into 1 mL sam-
ples. Subsequently, aliquots were stored at
–80 °C until urea analysis.
2.7. Inulin assay
A spectrophotometric assay was per-
formed as described by Restrick et al. [11].
Briefly, 200 µL of defrosted BALF or of
standard solution and its dilutions were
added to 800 µL of 5% perchloric acid
(PCA, Merck, Darmstadt, Germany), 500 µL
of 0.09 M resorcinol (Fluka, Buchs, Switzer-
land) in 95% ethanol and 1 500 µL of 30%
hypochloric acid (HCl, Merck, Darmstadt,
Germany). All samples and standards were
duplicated. The mixture was prepared in 
4 mL plastic tubes (Greiner, Frickenhausen,
Germany) and vortex-mixed before being
heated at 80 °C for one hour in a water bath.
Tubes were removed from the water bath
and cooled down to ambient temperature.
Absorbances of 1 mL aliquots were read at
413 nm using a spectrophotometer (Cam-
spec M302, Cambridge, UK) and 4.5 mL
cuvettes (Dispolab Kartell, Italy). A stan-
dard curve was plotted, and the inulin con-
centration was determined from the
absorbance of each BALF sample. All
assays and consequent calculations were
performed on four occasions. The intra-
assay and inter-assay coefficients of varia-
tion were 7.8 and 7.5%, respectively. 
2.8. Urea assay
Plasma urea was determined by using the
spectrophotometric BUN-Endpoint 20 kit
(Sigma Diagnostics, St. Louis, MO, USA).
The recommended instructions were slightly
modified for better precision in horse
plasma. The samples were defrosted and
vortex-mixed. Preliminary assays had shown
that better accuracy and repeatability of anal-
ysis were achieved by PCA-induced depro-
teinisation. Therefore, 250 µL of plasma
were added to 750 µL of 5% PCA (per-
chloric acid, Merck, Darmstadt, Germany).
PCA and plasma were vortex-mixed and
centrifuged for 2 min at 900 · g. Super-
natant was used for the urea assay. One vial
of reagent was prepared with 25 mL dis-
tilled water (instead of 20 mL, as suggested
by the manufacturer). Ten microliters
(instead of 5 µL, as suggested by the manu-
facturer) of plasma-PCA supernatant were
mixed to 500 µL of reagent and incubated
for 10 min. The assay was prepared in 1 mL
cuvettes (Dispolab Kartell, Italy) and
absorbance was read at 340 nm by a spec-
trophotometer (Camspec M302, Cambridge,
UK). Plasma urea concentration data were
calculated as recommended by the supplier,
but taking into account the dilution by PCA
(1:4). The intra- and inter-assay coefficient
of variation of this method was < 5%.
For BALF urea determination, the
method described by Rennard et al. [10]
was applied. The BUN-Endpoint 20 kit
(Sigma Diagnostics, St. Louis, MO, USA)
N. Kirschvink et al.150
was used. One vial of reagent was prepared
with 20 mL water. BALF was defrosted and
centrifuged for 2 min at 900 · g. Two hun-
dred-fifty microliters of BALF supernatant
were added to 500 µL reagent. After 10 min
of incubation, absorbance was read at
340 nm. A saline blank allowed the correc-
tion of reagent dilution due to the sample. A
further blank with lavage fluid alone was
also prepared to correct for optical
absorbance of the sample. After this modi-
fication, the coefficient of variation of the
assay was < 5% intra-assay and < 10% inter-
assay. All plasma and BALF samples were
assayed on two occasions.
2.9. Dilution factor calculations
2.9.1. Inulin dilution factor (Inu DF)
and proportion of PELF in BALF
(for details see Restrick et al. [11])
The concentration of inulin in BALF
expressed as the fraction of the concentration
of inulin in the instilled fluid is the dilution
factor (Inu DF):
Hence, 
Volume of PELF (mL) = [1 – Inu DF] ·
Volume BALF (mL).
The proportion of PELF in BALF is there-
fore:
2.9.2. Urea dilution factor (Ur DF) 
and proportion of PELF in BALF
(for details see Rennard et al. [10])
Based on the assumption that 
Urea [PELF] = Urea [plasma]
and the following equation calculating urea
dilution factor of BALF:
the proportion of PELF in BALF equals:
2.10. Statistical evaluation
Results of pulmonary function tests are
expressed as mean ± standard deviation
(SD). All results dealing with analysis of
urea and inulin are presented as mean ± stan-
dard error of mean (SEM). Data were com-
pared by one-way ANOVA and correlation
analyses were performed by simple regres-
sion. P < 0.05 was chosen as the level of
significance.
3. RESULTS
3.1. Inulin assay
Over the range of concentrations assayed,
absorbance was a linear function of inulin
concentration. The inulin dilution factor (Inu
DF) of healthy horses ranged from 0.863 to
0.985 (mean ± SEM, 0.934 ± 0.044) and
those of horses with heaves ranged from
0.882 to 0.982 (mean ± SEM, 0.937 ±
0.037). Individual results are reported in
Table II. The percentage of PELF in BALF
calculated by the Inu DF ranged from 1.47
to 13.71% (mean ± SEM, 6.61 ± 2.42%) in
healthy horses and from 1.78 to 11.77%
(mean ± SEM, 6.25 ± 1.95%) in heaves-
affected horses. The difference between
groups was not significant. 
3.2. Urea assay
Plasma urea concentrations of healthy
and heaves-affected horses ranged from 5.06
VolumeofPELF (mL)
VolumeofBALF(mL) = Ur DF.
Ur DF = BALFurea (mmol ⋅ L
– 1)
plasma urea (mmol ⋅ L– 1)
VolumeofPELF (mL)
VolumeofBALF(mL) = 1 – InuDF.
InuDF =
Concentrationof inulin in BALF(mg ⋅ mL– 1)
Concentrationof inulin in instilledfluid (mg ⋅ mL– 1)
.
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to 9.70 mmol·L–1 (mean ± SEM, 7.72 ±
0.81 mmol·L–1). BALF urea concentrations
of both groups ranged from 0.021 to 
0.133 mmol·L–1 (mean ± SEM, 0.059 ±
0.019 mmol·L–1). The individual Ur DF are
shown in Table II. The percentage of PELF
in BALF calculated by the urea dilution fac-
tor in healthy horses ranged from 0.550 to
1.175% (mean ± SEM, 0.785 ± 0.180%)
and in heaves-affected horses from 0.212
to 1.820% (mean ± SEM, 0.793 ± 0.419%).
There was no significant difference between
groups. Linear regression between plasma
urea and BALF urea was not significant,
neither for all individuals taken together,
nor after dividing them into healthy and
heaves-affected groups.
3.3. Comparison of inulin dilution 
factors with urea dilution factors
The percentage of PELF in BALF was
significantly higher when calculated by Inu
DF than by Ur DF (n = 10, P < 0.005) 
(Tab. II). Because of the widespread Inu DF
values, the difference between Inu DF and
Ur DF was no more significant when 
calculated separately for healthy horses 
(P = 0.074) and heaves-affected horses 
(P = 0.056) (Fig. 1). The correlation between
the inulin-calculated PELF % and the urea-
calculated PELF % was not significant (r =
0.157, P = 0.665) (Fig. 2).
4. DISCUSSION
In this study, inulin and urea, two dilu-
tional markers of PELF recovered by bron-
choalveolar lavage, were analysed in healthy
and heaves-affected horses. Moreover, this
was aimed at comparing inulin with urea
and evaluating the impact of airway disease
on the dilution of PELF. 
4.1. Inulin as a dilutional marker
Inulin appears to meet the theoretical cri-
teria of an exogenous marker of dilution of
BALF. It is not naturally present in the body,
is inert, and does not cross the pulmonary
barrier. Normand et al. [9] demonstrated
that in the lungs of foetal lambs, alveolar
epithelium is impermeable to radiolabelled
Table II. Inulin and urea dilution factors and respective PELF percentages.
Inu DF % PELFInua Ur DF % PELFUrb
Healthy horses
1 0.894 10.6 0.01175 1.175
2 0.863 13.7 0.00605 0.605
3 0.954 5.5 0.00550 0.550
4 0.985 1.5 0.00751 0.751
5 0.982 1.8 0.00845 0.845
Heaves-affected horses
1 0.963 3.7 0.00535 0.535
2 0.982 1.8 0.00813 0.813
3 0.960 4.0 0.00212 0.212
4 0.882 11.8 0.00584 0.584
5 0.899 10.1 0.01820 1.820
Mean ± SEM (n = 10) 6.43 ± 4.08 0.789 ± 0.299*
a % PELF Inu = [(1 – Inu DF) · 100].b % PELF Ur = (Ur DF · 100).
* Significantly different from % PELF Inu, P < 0.05.
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inulin, either administered intravenously or
instilled directly into the alveoli. Further-
more, inulin has no effect on cell viability
[11], which can be of major importance in
some fields of lung research. The use of
inulin in practice and in research could be
considered, because neither the preparation
of lavage solution nor the consecutive lavage
processing requires sophisticated equipment
or knowledge. In fact, after lavage process-
ing, samples could be stored at –80 °C and
were analysed several weeks after the inves-
tigation. The assay procedure itself was easy
and rapid, with satisfactory coefficients of
intra- and inter-variation (7.8 and 7.5%,
respectively). Our results are in line with
those of Restrick et al. [11]. They used inulin
as a dilutional marker in healthy and asth-
matic humans. The dilution factors (DF)
they reported were similar to those in our
study. These investigators did not observe a
significant difference between the DF cal-
culated in control patients and those in asth-
matics. Our data support this, as we found
similar DF in healthy and heaves-affected
horses. Inulin has also been used as an
exogenous marker in nasal lavages in chil-
dren [2] and in bronchoalveolar lavages in
dogs [3] and rats [14]. The initial concen-
tration of instilled inulin used in the latter
Figure 1. Percentage of
PELF in BALF in healthy
and heaves-affected horses.
Data are presented as mean
± SEM.
Figure 2. Correlation
between proportion of
PELF in BALF calculated
by the inulin (x-axis) and
the urea (y-axis) method.
Inulin and urea as a marker of dilution 153
study was much higher (3 mg·mL–1 instead
of 0.5 mg·mL–1), so that these results could
not be reliably compared with our data. 
4.2. Urea as a dilutional marker
Urea is the most commonly used endoge-
nous marker for calculations of PELF dilu-
tion. The major advantage is that no prepa-
ration of instillation fluid is necessary for
its use and that lavage processing is even
more simple than for inulin. By contrast,
this procedure requires blood sampling and
consecutive centrifugation for the prepara-
tion of plasma aliquots. The samples could
be stored at –80 °C until analysis. The coef-
ficient of variation of the urea assay was
also satisfactory (5% intra- and 10% inter-
assay). Our results were in agreement with
those of previous studies performed in
horses [7, 8] and humans [5, 10]. We did
not find any difference in DF by compar-
ing healthy to heaves-affected horses. In
healthy and lung-diseased infants, urea is
the dilutional marker which best standardises
the lavage concentrations, independently of
lung status [5]. There are concerns that dif-
fusion of urea into the lavage fluid from the
pulmonary epithelium may occur during
lavage and that epithelial lesions can
increase urea influx, in such a way that
PELF recovery is selectively overestimated
in patients with lung disease [5]. Regarding
these concerns, the standardisation of the
sampling technique appears to be of major
importance. Similar instilled fluid volumes,
dwell times and applied negative pressures
for the aspiration of lavage fluid should be
respected in order to reduce, or at least to
standardise, urea influx and epithelial lesion
due to the endoscope wedged in the bronchi. 
4.3. Comparison of inulin with urea 
as dilutional markers
As illustrated in Figure 1, the percentage
of PELF in BALF fluid was higher when
calculated by the inulin method than by the
urea method. The difference between the
techniques was significant when all horses,
healthy and heaves-affected, were consid-
ered (n = 10). The lack of significance
within the healthy and heaves-affected
groups was due to the small number of indi-
viduals (n = 5) and the widespread range of
results. The regression analysis revealed a
weak correlation between the PELF/BALF
percentages calculated by both methods
(Fig. 2). To the authors’ knowledge, no
information about the simultaneous use of
inulin and urea as dilutional markers has
been published. The problem of both tech-
niques lies in the fact that the modifications
of marker concentration are nearly negligi-
ble, because of the enormous dilution of
PELF [5, 10, 11]. In the case of inulin, the
dilution of the instilled fluid by PELF is
minimal, whereas the increase of urea in
recovered lavage fluid is also minimal.
Therefore, both techniques need to be very
sensitive. A real validation of the inulin
method by the urea method or vice versa is
not possible, as no reference method exists.
Despite these limitations, in their inulin-
study Restrick et al. [11] strongly recom-
mended the use of inulin and urea as mark-
ers. Indeed, by using inulin as an external
marker, neither “contamination” due to
marker influx nor marker loss due to epithe-
lial crossing may occur. But incomplete
mixing of lavage fluid with PELF can lead
to inaccurate sampling. In the case of inulin,
large lavage samples and long dwell times
seem to be recommended. The opposite is
true if urea is used as an endogenous marker.
In fact, urea cannot be “lost” by incomplete
lavage mixing, but can be highly diluted.
Nevertheless, large lavage volumes and long
dwell times favour urea influx and overes-
timation of PELF recovery. The combined
use of an external marker of dilution (e.g.,
inulin) and an internal marker (e.g., urea)
may allow more accurate determination of
PELF, providing an upper and lower limit,
respectively, of the proportion of PELF sam-
pled in BALF. A high discrepancy between
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the results obtained by both methods would
either indicate that incomplete PELF-lavage
mixing occurred during bronchoalveolar
lavage, or that large lavage fluid volumes
and/or increased dwell time allowed urea
influx into lavage fluid. In the case of an
incomplete PELF-lavage fluid mixing, the
Ur DF may be diminished to a larger extent
than the Inu DF, which would lead to a
higher PELF recovery calculated by the Inu
DF than by the Ur DF. In the case of large
lavage volumes, which are often combined
with increased dwell times, the urea influx
may be proportionally higher than the inulin
dilution. Consequently, the urea PELF
recovery would be increased to a higher
extent than the inulin recovery. Further stud-
ies testing these hypotheses by assessing
the impact of lavage volume and dwell time
on the Inu DF and the Ur DF would be inter-
esting. The establishment of “acceptable”
discrepancy values between both methods
should also be attempted.
In conclusion, we have shown that inulin
and urea are valid dilutional markers of
BALF in horses and that recovery of PELF
is independent from lung disease. There was
no significant correlation between both
methods, but their combined use may pro-
vide information about the quality of fluid
mixing during bronchoalveolar lavage.
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